We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

88 hedge funds and large institutions have $345M invested in GenMark Diagnostics, Inc in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 26

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

1% less funds holding

Funds holding: 89 → 88 (-1)

12% less capital invested

Capital invested by funds: $392M → $345M (-$47.2M)

100% less call options, than puts

Call options by funds: $1K | Put options by funds: $272K

Holders
88
Holders Change
-1
Holders Change %
-1.12%
% of All Funds
2.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
39
Reduced
26
Closed
9
Calls
$1K
Puts
$272K
Net Calls
-$271K
Net Calls Change
-$289K

Top Buyers

1
CCM
Cadian Capital Management
New York
+$11.5M
2
NC
Northpointe Capital
Michigan
+$11.3M
3
VAM
Visium Asset Management
New York
+$2.9M
4
DCM
Driehaus Capital Management
Illinois
+$2.31M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.13M

Top Sellers

1
JP Morgan Chase
JP Morgan Chase
New York
-$8.1M
2
FAM
Fred Alger Management
New York
-$3.76M
3
Parnassus Investments
Parnassus Investments
California
-$2.99M
4
CCM
Camber Capital Management
Massachusetts
-$2.72M
5
JGC
J. Goldman & Co
New York
-$2.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
51
Candriam SCA
Luxembourg
$354K – – –
GA
52
Geneva Advisors
Illinois
$344K +$176K +19,037 +77%
HighTower Advisors
53
HighTower Advisors
Illinois
$319K +$27.7K +3,000 +8%
CS
54
Credit Suisse
Switzerland
$297K +$5.65K +611 +2%
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
$294K +$13.2K +1,429 +4%
PP
56
PDT Partners
New York
$233K +$273K +29,569 New
BA
57
BlackRock Advisors
Delaware
$226K +$5.22K +564 +2%
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
$221K +$6.57K +710 +3%
NFA
59
Nationwide Fund Advisors
Ohio
$213K – – –
AIG
60
American International Group
New York
$195K +$268 +29 +0.1%
MC
61
Menta Capital
California
$191K +$225K +24,310 New
VOYA Investment Management
62
VOYA Investment Management
Georgia
$180K – – –
SIP
63
Stoneridge Investment Partners
Pennsylvania
$170K +$199K +21,552 New
PG
64
PEAK6 Group
Illinois
$138K +$162K +17,500 New
State Board of Administration of Florida Retirement System
65
State Board of Administration of Florida Retirement System
Florida
$123K +$10.5K +1,130 +8%
UBS AM
66
UBS AM
Illinois
$111K – – –
Morgan Stanley
67
Morgan Stanley
New York
$100K -$317K -34,281 -73%
UBS Group
68
UBS Group
Switzerland
$100K -$87.9K -9,500 -43%
D.E. Shaw & Co
69
D.E. Shaw & Co
New York
$86K -$238K -25,731 -70%
CC
70
Cannell & Co
New York
$79K – – –
Canada Life
71
Canada Life
Manitoba, Canada
$70K – – –
BNP Paribas Financial Markets
72
BNP Paribas Financial Markets
France
$69.7K +$49.5K +5,349 +153%
TWA
73
TCI Wealth Advisors
Arizona
$63K +$18.5K +2,000 +33%
Legal & General Group
74
Legal & General Group
United Kingdom
$62K – – –
Teacher Retirement System of Texas
75
Teacher Retirement System of Texas
Texas
$39K +$31.2K +3,375 +220%
1 2
3
4

GNMK Hedge Fund Activity: Q3 2015 in Review

88 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2015, worth a combined $345M — down 12% from $392M a quarter earlier.

Fund positioning in GNMK was balanced in Q3 2015: 9 funds opened new positions, 9 closed out, 39 added to existing stakes and 26 trimmed.

The largest buyer was Cadian Capital Management, adding an estimated $11.5M. The largest seller was JP Morgan Chase, cutting an estimated $8.1M.

  • 88 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2015, down from 89 in Q2 2015.
  • Funds reported $345M of GenMark Diagnostics, Inc stock for Q3 2015, down 12% quarter-over-quarter.
  • 9 funds opened new GenMark Diagnostics, Inc positions in Q3 2015 and 9 closed out, a net change of 0 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q3 2015 was Cadian Capital Management, an estimated $11.5M added.
  • The largest GenMark Diagnostics, Inc seller in Q3 2015 was JP Morgan Chase, an estimated $8.1M sold.

Based on aggregated 13F filings for Q3 2015.